Anekabio LLC
Publicly observedGainesville, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Gainesville | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Anekabio LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | JRP2ABF81TZ8 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant23 Sept 2025Publicly observed
NIH SBIR/STTR award: Development and Validation of Efficacy Biomarkers for QTE Therapy in Friedreich's Ataxia
USD 245,560.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant23 Sept 2025Publicly observed
NIH SBIR/STTR award: Development and Validation of Efficacy Biomarkers for QTE Therapy in Friedreich's Ataxia
USD 454,437.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.